Doxa AB (publ) Logo

Doxa AB (publ)

DOXA.ST

(2.5)
Stock Price

1,09 SEK

0.87% ROA

0.95% ROE

21.78x PER

Market Cap.

1.385.801.340,00 SEK

0% DER

0% Yield

180.95% NPM

Doxa AB (publ) Stock Analysis

Doxa AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Doxa AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (25.43%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

With a remarkably low PBV ratio (0.5x), the stock offers substantial upside potential at a bargain price.

4 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

5 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-1) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Doxa AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Doxa AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Doxa AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Doxa AB (publ) Revenue
Year Revenue Growth
2007 1.823.000
2008 5.000 -36360%
2009 49.000 89.8%
2010 863.000 94.32%
2011 1.005.000 14.13%
2012 2.193.000 54.17%
2013 6.159.000 64.39%
2014 8.998.000 31.55%
2015 15.013.000 40.07%
2016 17.544.000 14.43%
2017 16.330.000 -7.43%
2018 33.758.000 51.63%
2019 19.274.000 -75.15%
2020 8.541.000 -125.66%
2021 10.900.000 21.64%
2022 5.200.000 -109.62%
2023 13.600.000 61.76%
2023 9.900.000 -37.37%
2024 18.400.000 46.2%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Doxa AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2007 32.007.000
2008 31.354.000 -2.08%
2009 15.038.000 -108.5%
2010 8.841.000 -70.09%
2011 10.548.000 16.18%
2012 3.394.000 -210.78%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 782.000 100%
2018 769.000 -1.69%
2019 556.000 -38.31%
2020 561.000 0.89%
2021 800.000 29.88%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Doxa AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 5.309.000
2008 8.327.000 36.24%
2009 3.654.000 -127.89%
2010 4.131.000 11.55%
2011 9.039.000 54.3%
2012 3.570.000 -153.19%
2013 15.046.000 76.27%
2014 16.199.000 7.12%
2015 17.777.000 8.88%
2016 17.986.000 1.16%
2017 15.317.000 -17.43%
2018 12.702.000 -20.59%
2019 10.863.000 -16.93%
2020 9.971.000 -8.95%
2021 31.200.000 68.04%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Doxa AB (publ) EBITDA
Year EBITDA Growth
2007 -38.468.000
2008 -41.057.000 6.31%
2009 -31.696.000 -29.53%
2010 -29.150.000 -8.73%
2011 -46.905.000 37.85%
2012 -23.614.000 -98.63%
2013 -18.742.000 -26%
2014 -17.384.000 -7.81%
2015 -15.400.000 -12.88%
2016 -9.329.000 -65.08%
2017 -8.550.000 -9.11%
2018 9.950.000 185.93%
2019 -10.423.000 195.46%
2020 -12.490.000 16.55%
2021 -33.300.000 62.49%
2022 -28.600.000 -16.43%
2023 8.400.000 440.48%
2023 -8.100.000 203.7%
2024 53.600.000 115.11%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Doxa AB (publ) Gross Profit
Year Gross Profit Growth
2007 1.823.000
2008 5.000 -36360%
2009 25.000 80%
2010 516.000 95.16%
2011 -8.012.000 106.44%
2012 -1.470.000 -445.03%
2013 3.129.000 146.98%
2014 6.449.000 51.48%
2015 10.641.000 39.39%
2016 16.077.000 33.81%
2017 14.000.000 -14.84%
2018 30.168.000 53.59%
2019 11.247.000 -168.23%
2020 8.397.000 -33.94%
2021 7.900.000 -6.29%
2022 -35.600.000 122.19%
2023 13.600.000 361.76%
2023 -32.700.000 141.59%
2024 -23.600.000 -38.56%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Doxa AB (publ) Net Profit
Year Net Profit Growth
2007 -38.943.000
2008 -50.288.000 22.56%
2009 -33.597.000 -49.68%
2010 -16.455.000 -104.18%
2011 -62.886.000 73.83%
2012 -37.379.000 -68.24%
2013 -19.490.000 -91.79%
2014 -18.488.000 -5.42%
2015 -15.932.000 -16.04%
2016 -10.743.000 -48.3%
2017 -10.560.000 -1.73%
2018 8.018.000 231.7%
2019 -11.273.000 171.13%
2020 -13.692.000 17.67%
2021 76.200.000 117.97%
2022 -33.000.000 330.91%
2023 2.242.400.000 101.47%
2023 542.900.000 -313.04%
2024 24.000.000 -2162.08%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Doxa AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 -1
2008 -1 0%
2009 -1 0%
2010 0 0%
2011 -4 100%
2012 -2 -50%
2013 -1 -100%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 1 0%
2022 0 0%
2023 5 100%
2023 1 -300%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Doxa AB (publ) Free Cashflow
Year Free Cashflow Growth
2007 -37.181.000
2008 -43.819.000 15.15%
2009 -6.563.000 -567.67%
2010 -33.405.000 80.35%
2011 -53.535.000 37.6%
2012 -29.896.000 -79.07%
2013 -20.248.000 -47.65%
2014 -18.571.000 -9.03%
2015 -17.368.000 -6.93%
2016 -12.369.000 -40.42%
2017 -9.052.000 -36.64%
2018 10.114.000 189.5%
2019 -9.924.000 201.91%
2020 -15.658.000 36.62%
2021 -18.600.000 15.82%
2022 -39.400.000 52.79%
2023 -23.900.000 -64.85%
2023 167.300.001 114.29%
2024 -14.800.000 1230.41%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Doxa AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2007 -37.140.000
2008 -22.875.000 -62.36%
2009 -6.453.000 -254.49%
2010 -30.247.000 78.67%
2011 -50.419.000 40.01%
2012 -29.896.000 -68.65%
2013 -20.248.000 -47.65%
2014 -18.201.000 -11.25%
2015 -17.344.000 -4.94%
2016 -9.705.000 -78.71%
2017 -8.212.000 -18.18%
2018 10.742.000 176.45%
2019 -9.174.000 217.09%
2020 -14.282.000 35.77%
2021 -18.600.000 23.22%
2022 -38.500.000 51.69%
2023 -23.900.000 -61.09%
2023 -37.800.000 36.77%
2024 -14.800.000 -155.41%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Doxa AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2007 41.000
2008 20.944.000 99.8%
2009 110.000 -18940%
2010 3.158.000 96.52%
2011 3.116.000 -1.35%
2012 0 0%
2013 0 0%
2014 370.000 100%
2015 24.000 -1441.67%
2016 2.664.000 99.1%
2017 840.000 -217.14%
2018 628.000 -33.76%
2019 750.000 16.27%
2020 1.376.000 45.49%
2021 0 0%
2022 900.000 100%
2023 0 0%
2023 -205.100.001 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Doxa AB (publ) Equity
Year Equity Growth
2007 515.000
2008 -10.026.000 105.14%
2009 23.320.000 142.99%
2010 6.904.000 -237.78%
2011 26.409.000 73.86%
2012 12.602.000 -109.56%
2013 4.658.000 -170.55%
2014 21.401.000 78.23%
2015 11.295.000 -89.47%
2016 312.000 -3520.19%
2017 11.884.000 97.37%
2018 20.119.000 40.93%
2019 8.921.000 -125.52%
2020 9.442.000 5.52%
2021 869.800.000 98.91%
2022 1.769.300.000 50.84%
2023 3.363.400.000 47.4%
2023 3.474.000.000 3.18%
2024 3.107.000.000 -11.81%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Doxa AB (publ) Assets
Year Assets Growth
2007 30.833.000
2008 30.397.000 -1.43%
2009 28.499.000 -6.66%
2010 47.554.000 40.07%
2011 35.931.000 -32.35%
2012 17.623.000 -103.89%
2013 12.335.000 -42.87%
2014 24.607.000 49.87%
2015 19.417.000 -26.73%
2016 14.410.000 -34.75%
2017 22.721.000 36.58%
2018 28.784.000 21.06%
2019 16.626.000 -73.13%
2020 14.478.000 -14.84%
2021 878.800.000 98.35%
2022 1.787.600.000 50.84%
2023 3.390.400.000 47.27%
2023 3.754.800.000 9.7%
2024 3.492.900.000 -7.5%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Doxa AB (publ) Liabilities
Year Liabilities Growth
2007 30.318.000
2008 40.423.000 25%
2009 5.179.000 -680.52%
2010 40.650.000 87.26%
2011 9.522.000 -326.91%
2012 5.021.000 -89.64%
2013 7.677.000 34.6%
2014 3.206.000 -139.46%
2015 8.122.000 60.53%
2016 14.098.000 42.39%
2017 10.837.000 -30.09%
2018 8.665.000 -25.07%
2019 7.705.000 -12.46%
2020 5.036.000 -53%
2021 9.000.000 44.04%
2022 18.300.000 50.82%
2023 27.000.000 32.22%
2023 280.800.000 90.38%
2024 385.900.000 27.24%

Doxa AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.03
Net Income per Share
0.05
Price to Earning Ratio
21.78x
Price To Sales Ratio
82.49x
POCF Ratio
-14.06
PFCF Ratio
-29.42
Price to Book Ratio
0.21
EV to Sales
81.79
EV Over EBITDA
30.74
EV to Operating CashFlow
-29.17
EV to FreeCashFlow
-29.17
Earnings Yield
0.05
FreeCashFlow Yield
-0.03
Market Cap
1,39 Bil.
Enterprise Value
1,37 Bil.
Graham Number
2.37
Graham NetNet
-0.58

Income Statement Metrics

Net Income per Share
0.05
Income Quality
0.09
ROE
0.01
Return On Assets
0.01
Return On Capital Employed
0.17
Net Income per EBT
1
EBT Per Ebit
0.06
Ebit per Revenue
32.07
Effective Tax Rate
-28.07

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-1.18
Operating Profit Margin
32.07
Pretax Profit Margin
1.81
Net Profit Margin
1.81

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.08
Free CashFlow per Share
-0.08
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
5.04
Return on Tangible Assets
0.01
Days Sales Outstanding
514.91
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0.71
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
5,06
Tangible Book Value per Share
5.06
Shareholders Equity per Share
5.06
Interest Debt per Share
0.03
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-0.26
Current Ratio
0.16
Tangible Asset Value
3,11 Bil.
Net Current Asset Value
-0,35 Bil.
Invested Capital
-186300000
Working Capital
-0,19 Bil.
Intangibles to Total Assets
0
Average Receivables
0,02 Bil.
Average Payables
0,11 Bil.
Average Inventory
-8350000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Doxa AB (publ) Dividends
Year Dividends Growth

Doxa AB (publ) Profile

About Doxa AB (publ)

Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide. It offers Crown & Bridge, a dental cement that is used for permanent cementing of crowns and bridges. The company was founded in 1987 and is based in Uppsala, Sweden.

CEO
Mr. Kaj Gronvall
Employee
6
Address
Axel Johanssons gata 4-6
Uppsala, 754 50

Doxa AB (publ) Executives & BODs

Doxa AB (publ) Executives & BODs
# Name Age
1 Mr. Kaj Gronvall
Chief Executive Officer
70
2 Mr. Christian Lindgren
Chief Financial Officer
70

Doxa AB (publ) Competitors

AegirBio AB (publ) Logo
AegirBio AB (publ)

AEGIR.ST

(1.2)
Mantex AB (publ) Logo
Mantex AB (publ)

MANTEX.ST

(0.8)
Genovis AB (publ.) Logo
Genovis AB (publ.)

GENO.ST

(2.8)
Vestum AB (publ) Logo
Vestum AB (publ)

VESTUM.ST

(2.5)